A Case Report with Plasmablastic Lymphoma of the Jejunum

被引:27
作者
Cha, Jae Myung [1 ]
Lee, Joung Il
Joo, Kwang Ro
Jung, Sung Won
Shin, Hyun Phil
Lee, Jae Jin
Kim, Gyo Young [2 ]
机构
[1] Univ Kyunghee, Coll Med, Dept Internal Med, EW Neo Med Ctr, 149 Sangil Dong, Seoul 134727, South Korea
[2] Univ Kyunghee, Coll Med, Dept Pathol, Seoul 134727, South Korea
关键词
HIV-negative; Jejunum; Plasmablastic Lymphoma; ORAL-CAVITY; ENTITY;
D O I
10.3346/jkms.2010.25.3.496
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasmablastic lymphoma (PBL) is a recently identified entity that is considered to be a type of diffuse large B-cell lymphoma with a unique immunophenotype and a predilection for the oral cavity of patients with the human immunodeficiency virus (HIV). Although its clinical features may help in the differential diagnosis, an extraoral location in a patient without HIV makes it more difficult to suspect clinically. This case report is the first to describe a patient with PBL originating from the jejunum in a 60-yr-old, HIV-seronegative man. Computed tomography of the face, chest and abdomen showed about a 9.4x9.0 cm mass of the proximal jejunum, multiple masses in the musculoskeletal soft tissue, and multiple lymphadenopathies. The histological examinations demonstrated a large cell lymphoma with plasmablastic differentiation. The neoplastic cells were diffusely positive for MUM1, epithelial membrane antigen and lambda light chains, and focally positive for CD79a; but negative for CD3, CD20, CD30, CD34, CD45RO, CD56, CD99, and CD117. The proliferation index by Ki-67 immunohistochemistry was approximately 70%. These findings were compatible with the diagnosis of PBL. The findings in this case suggest that PBL should be included in the differential diagnosis of a small bowel mass even in a HIV-negative patient.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 9 条
  • [1] Brown R S, 1998, Clin Oncol (R Coll Radiol), V10, P327, DOI 10.1016/S0936-6555(98)80089-7
  • [2] Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities
    Colomo, L
    Loong, F
    Rives, S
    Pittaluga, S
    Martínez, A
    López-Guillermo, A
    Ojanguren, J
    Romagosa, V
    Jaffe, ES
    Campo, E
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (06) : 736 - 747
  • [3] Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection
    Delecluse, HJ
    Anagnostopoulos, I
    Dallenbach, F
    Hummel, M
    Marafioti, T
    Schneider, U
    Huhn, D
    SchmidtWesthausen, A
    Reichart, PA
    Gross, U
    Stein, H
    [J]. BLOOD, 1997, 89 (04) : 1413 - 1420
  • [4] A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
    Falini, B
    Fizzotti, M
    Pucciarini, A
    Bigerna, B
    Marafioti, T
    Gambacorta, M
    Pacini, R
    Alunni, C
    Natali-Tanci, L
    Ugolini, B
    Sebastiani, C
    Cattoretti, G
    Pileri, S
    Dalla-Favera, R
    Stein, H
    [J]. BLOOD, 2000, 95 (06) : 2084 - 2092
  • [5] Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations
    Flaitz, CM
    Nichols, CM
    Walling, DM
    Hicks, MJ
    [J]. ORAL ONCOLOGY, 2002, 38 (01): : 96 - 102
  • [6] Harris N L, 2000, Hematol J, V1, P53, DOI 10.1038/sj.thj.6200013
  • [7] Lin Y, 2001, ARCH PATHOL LAB MED, V125, P282
  • [8] Pruneri G, 1998, HAEMATOLOGICA, V83, P87
  • [9] Riedel DJ, 2008, LANCET INFECT DIS, V8, P261, DOI 10.1016/S1473-3099(08)70067-7